A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Researchers are looking for new ways to treat rheumatoid arthritis (RA). Methotrexate (MTX) is a standard (usual) treatment for RA. However, MTX and other current treatments may not work well to treat RA symptoms for many people. Researchers are doing this trial to learn if a trial medicine called MK-8690 can treat symptoms of active RA in people who are taking MTX. The goal of this study is to learn if MK-8690 works better than placebo to improve RA symptoms.
Epistemonikos ID: cde40ca7b0e5c12932cc9483b8789f2250f066c9
First added on: Oct 27, 2026